Daniel J Shepherd
Overview
Explore the profile of Daniel J Shepherd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
103
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shepherd D, Gordetsky J
Curr Urol Rep
. 2025 Feb;
26(1):28.
PMID: 39921827
Purpose Of Review: Digital pathology, the use of digital images for histopathologic diagnosis, is transforming the practice of pathology. This review discusses the ability of digital pathology to assist with...
2.
Villalba J, Hilburn C, Garlin M, Elliott G, Li Y, Kunitoki K, et al.
Am J Respir Crit Care Med
. 2022 Jun;
206(7):857-873.
PMID: 35671465
The leading cause of death in coronavirus disease 2019 (COVID-19) is severe pneumonia, with many patients developing acute respiratory distress syndrome (ARDS) and diffuse alveolar damage (DAD). Whether DAD in...
3.
Stuart K, Shepherd D, Kruger M, Singh E
Ophthalmic Epidemiol
. 2021 Dec;
29(6):681-687.
PMID: 34935580
Purpose: To determine the frequency and incidence rate of retinoblastoma in children in South Africa from 2004 to 2018. Methods: Incident cases of histologically diagnosed retinoblastoma were identified from the...
4.
Shepherd D, Tabb E, Kunitoki K, Zhang M, Kem M, Barth J, et al.
Mod Pathol
. 2021 Dec;
35(5):615-624.
PMID: 34880448
Lymphocyte-activation gene 3 (LAG-3) modulates the tumor microenvironment through immunosuppressive effects. Its associations with clinicopathologic parameters and prognostic significance in non-small-cell lung carcinomas remain unclear. We examined LAG-3 expression in...
5.
Shepherd D, Miller T, Forst D, Jones P, Nardi V, Martinez-Lage M, et al.
Oncologist
. 2021 May;
26(11):919-924.
PMID: 34041811
Rearrangements involving the neurotrophic receptor tyrosine kinase (NTRK) gene family have been reported in diverse tumor types, and NTRK-targeted therapies have recently been approved. In this article, we report a...
6.
Harris C, Shepherd D, Bland D, Anim W, Sohani A, Duncan L, et al.
J Am Acad Dermatol
. 2021 May;
86(6):1354-1356.
PMID: 33989696
No abstract available.
7.
Bearse M, Hung Y, Krauson A, Bonanno L, Boyraz B, Harris C, et al.
Mod Pathol
. 2021 Mar;
34(7):1345-1357.
PMID: 33727695
COVID-19 has been associated with cardiac injury and dysfunction. While both myocardial inflammatory cell infiltration and myocarditis with myocyte injury have been reported in patients with fatal COVID-19, clinical-pathologic correlations...
8.
Yun J, Johans S, Shepherd D, Martin B, Joyce C, Borys E, et al.
J Neurol Surg B Skull Base
. 2020 Dec;
81(6):651-658.
PMID: 33381369
Most pituitary adenomas are of soft consistency and can be resected during surgery with routine suction instruments. However, fibrous adenomas may require more aggressive techniques. The ability to predict consistency...
9.
Shepherd D, Tsai S, Cappucci S, Wu J, Farrer R, Kartje G
J Neuropathol Exp Neurol
. 2017 Aug;
76(8):683-696.
PMID: 28789474
Ischemic stroke is a leading cause of adult disability with no pharmacological treatments to promote the recovery of lost function. Neutralizing antibodies against the neurite outgrowth inhibitor Nogo-A have emerged...
10.
Shepherd D, Tsai S, OBrien T, Farrer R, Kartje G
Front Neurosci
. 2016 Nov;
10:467.
PMID: 27803646
Ischemic stroke is a leading cause of adult disability, including cognitive impairment. Our laboratory has previously shown that treatment with function-blocking antibodies against the neurite growth inhibitory protein Nogo-A promotes...